(2008). A et al. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother
(2007). A et al. Vancomycin in vitro bactericidal activity and its relationship to efﬁcacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother
(2002). Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother
(2004). Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin Infect Dis
(2002). Analysis of the genetic variability of genes encoding the RNA III-activating components Agr and TRAP in a population of Staphylococcus aureus strains isolated from cows with mastitis.
(2006). Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
(2005). Decreasing in vitro susceptibility of clinical Staphylococcus aureus isolates to vancomycin at the New York Hospital: quantitative testing redux. Clin Infect Dis
(2006). Eliopoulos GM. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy. Clin Infect Dis
(2003). Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother
(2006). High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efﬁ-cacy and toxicity. Arch Intern Med
(2006). Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period.
(2006). Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing:
(2002). Methicillin-resistant Staphylococcus aureus bloodstream infections failing vancomycin: results of increasing vancomycin versus adding quinupristin–dalfopristin to vancomycin. In:
(2008). Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit.
(2004). Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein.
(2003). Pulsed-ﬁeld gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates in the United States: establishing a national database.
(2004). spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation.
(2001). Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother
(2002). The efﬁcacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin.
(2007). Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001–05. J Antimicrob Chemother